Medicare, Medicaid to cover weight loss drug for heart disease risk
By
John Roszkowski
Mar 25, 2024
The Centers for Medicare & Medicaid Services disclosed last week it will provide coverage for the popular weight loss drug Wegovy for patients at high risk for cardiovascular disease and stroke.
Clinical briefs for Monday, March 25
By
John Roszkowski
Mar 25, 2024
Long genes linked to aging … Fat buildup in brain cells may cause Alzheimer’s … Drug shows no benefit for dry age-related macular degeneration in NIH trial … Neurologic disease may be higher for...
NIH to invest an additional $515M for long COVID research
By
John Roszkowski
Feb 16, 2024
The National Institutes of Health has announced plans to provide an additional $515 million in funding over the next four years for the research and treatment of long COVID.